EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Klinische Studie (Phase II)LeserbriefMultizentrische Studie

Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia

Carmen Mestre-Durán iD, Odelaisy León-Triana, Halin Bareke, Lidia Pertíñez, Laura Clares-Villa, David Bueno, Daniel Lozano-Ojalvo, Alfonso Navarro-Zapata, Luisa Sisinni, Isabel Badell-Serra, Marta González-Vicent, Cristina Beléndez iD und 12 weitere

American Journal of Hematology · 2025

DOI: 10.1002/ajh.70023 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Carmen Mestre-Durán und 23 weiteren Autor:innen. Beteiligte Einrichtung: CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Interleukin-15, Killer Cells, Natural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: CRIS Cancer Foundation, Ministry of Universities through the European Union NextGenerationEU, Universidad de Castilla-La Mancha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Phase I/II clinical trial was conducted in pediatric patients with high-risk malignancies to assess the safety and efficacy of NK cell infusion post-haplo-HSCT. Patients received either alloreactive NK cells from KIR/HLA-mismatched donors or IL-15-stimulated NK cells from KIR/HLA-matched donors, across three dose-escalating cohorts. The IL15-NK cell infusion product demonstrated enhanced activating receptor expression and functional capacity. Increased NKG2D expression was observed in NK cells from patients receiving IL15-NK cells. One-year follow-up showed accelerated immune reconstitution in both the allo-NK and IL15-NK cell arms. IL15-NK recipients exhibited a pro-inflammatory cytokine profile (IL-2, IL-4, IL-6, IFN-γ). Elevated CD69 expression was associated with a higher risk of transplant-related complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveInterleukin-15Killer Cells, NaturalLeukemiaTransplantation, HaploidenticalAdolescentChildChild, PreschoolFemaleHumansInfantMaleAntigens, Differentiation, T-LymphocyteNK Cell Lectin-Like Receptor Subfamily KAntigens, CDLectins, C-TypeCD69 Antigens

Stichwörter der Autor:innen

CD69IL15NK cellgraft‐versus‐leukemiahaploidentical hematopoietic stem cell transplantationpediatric acute leukemia

Substanzen

Antigens, Differentiation, T-LymphocyteInterleukin-15NK Cell Lectin-Like Receptor Subfamily KAntigens, CDLectins, C-TypeCD69 AntigensIL15 protein, humanKLRK1 protein, human

Autor:innen und Institutionen

  • CIBERER-ISCIII, IdiPAZ-CNIO Pediatric Onco-Hematology Clinical Research Unit, Madrid, Spain.
  • Biostatistics Unit, Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Pediatric Hemato-Oncology, Hospital Santa Creu I Sant Pau, Barcelona, Spain.
  • Pediatric Hemato-Oncology, Niño Jesús University Children's Hospital, Madrid, Spain.

ORCID-Profile: Carmen Mestre-Durán, Cristina Beléndez, Jordi Cano-Ochando, María Eugenia Fernández-Santos, Antonio Pérez-Martínez

Förderung

  • CRIS Cancer Foundation
  • Ministry of Universities through the European Union NextGenerationEU
  • Universidad de Castilla-La Mancha
  • Instituto de Salud Carlos III

Zitieren

APA

Mestre-Durán, C., León-Triana, O., Bareke, H., Pertíñez, L., Clares-Villa, L., Bueno, D., Lozano-Ojalvo, D., Navarro-Zapata, A., Sisinni, L., Badell-Serra, I., González-Vicent, M., Beléndez, C., Palomo-Moraleda, P., Mozo, Y., Galán, V., Artázcoz, M. F., Echecopar, C., Gasior, M., Al-Akioui, K., …, & Pérez-Martínez, A. (2025). Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.70023

Vancouver

Mestre-Durán C, León-Triana O, Bareke H, Pertíñez L, Clares-Villa L, Bueno D, et al. Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia. American Journal of Hematology. 2025. doi:10.1002/ajh.70023

BibTeX
@article{MestreDurn2025,
  author = {Mestre-Durán, Carmen and León-Triana, Odelaisy and Bareke, Halin and Pertíñez, Lidia and Clares-Villa, Laura and Bueno, David and Lozano-Ojalvo, Daniel and Navarro-Zapata, Alfonso and Sisinni, Luisa and Badell-Serra, Isabel and González-Vicent, Marta and Beléndez, Cristina and Palomo-Moraleda, Pilar and Mozo, Yasmina and Galán, Víctor and Artázcoz, Mikel Fernández and Echecopar, Carlos and Gasior, Mercedes and Al-Akioui, Karima and Cano-Ochando, Jordi and Guerra-García, Pilar and Fernández-Santos, María Eugenia and Aguirre-Portolés, Cristina and Pérez-Martínez, Antonio},
  title = {Ex Vivo IL ‐15‐Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.70023}
}
Kostenlos starten →